Given the crucial role of p53 in preventing abnormal cell proliferation and maintaining genomic integrity, there is a strong interest in developing non-genotoxic pharmacological strategies to modulate p53, aiming to enhance the selectivity and effectiveness of cancer cell elimination [20,21]. This evidence concerns the gene TP53 and cancer.